Leader : Ana Ferreiro, CR1, Inserm
Our team was created in July 2003 thanks to the support of the “Avenir” programme. It has a dual objective: on one hand, the characterisation of the phenotype and genetic bases of different forms of congenital myopathy with core-type lesions, and on the other, the study of the physiopathological mechanisms involved in these diseases.
Team 7 is composed of :
• Ana Ferreiro, MD, PhD, neurologist, CR1 INSERM
• Maud Beuvin, ingeneer assistant
• Sandrine Arbogast, PhD, post-doctoral researcher
• Carlo Maria Vincitorio, MD, PhD student
• Susana Quijano-Roy, MD, PhD, PH